Latest article
ViaCyte Broadcasts Initiation of Section 2 Research of Encapsulated Cell Remedy for Sort 1...
SAN DIEGO, February 3, 2021 / PRNewswire / - ViaCyte, Inc., a clinical-stage regenerative medicine company, announced today that the first patients with...
Analysis Reveals Majority Of Insured Folks With Kind 2 Diabetes Complement Their Prescribed Quantity...
PARSIPPANY, NJ, May 27, 2021 / PRNewswire / - People living with type 2 diabetes in the United States may not be prescribed enough...
‘Weak’ and ‘robust’ cells bonding boosts physique’s diabetes battle
Scientists have expanded our understanding of how “weak” cells connect with their more mature cellular counterparts to increase the body's production of insulin and...